293480.KS
Hana Pharm Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 8,420.00
−1.17%Margins
Gross margin
61.5%
EBITDA margin
16.8%
EBIT margin
11.6%
Net margin
7.1%
FCF margin
-21.4%
5.3%
Return on equity
3.9%
Return on assets
7.1%
Return on invested capital
0.56x
Asset turnover
KRW 16.4B
Cash from operations
KRW 973
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026